ATP Barcelona 2017

MLC versus Cerrobend blocking:

N=8

mlc

17.3(5.1) 12.0(3.3) 0.60(0.0) cerrobend

Mean (1SD) V20 (%)

19.9(5.0) 14.8(3.1) 0.46(0.1)

mean lung (Gy)

CI

V 20

Actuarial incidence ≥ grade 2 pneumonitis at 24 months

<22% 22-31% 32-40% >40%

0 % 7 %

13 %

36 % Ref: Graham MV et al. IJROBP 45, 323-329, 1999

47

Lagerwaard et al: R&O, 2001